References

Batki, S.L.  Treatment of intravenous drug users with AIDS: 
The role of methadone maintenance. 
Journal
of Psychoactive Drugs
1988 20: 213-216.



Legal Action Center. Beazer vs New York City Transit
Authority: A Landmark Decision on Methadone Maintenance

[Report].  New York:
National Institute on Drug Abuse, 1975.

 

Des
Jarlais, D.C.; Friedman, S.R.; Novick, D.M. et al.  HIV-1 infection among intravenous drug users in Manhattan. 
Journal
of the American Medical Association
1989 261: 1008-1012.

 

Dole,
V.P.; Nyswander, M.E. Heroin addiction: Metabolic disease. Archives of Internal Medicine
1967 120: 19-24.

 

Dole,
V.P.; Nyswander, M.E.  A
medical treatment for diacetylmorphine (heroin) addiction.  Journal of the American Medical Association 1965 (August 23)
193(8): 646-650.

 

Dole,
V.P.; Nyswander, M.E.; Kreek, M.J. 
Narcotic blockade.  Archives
of Internal Medicine
1966 
(October) 118:304-309.

 

Goldstein,
D.  Personal communication,
Eli Lilly Pharmaceuticals, 1992.

 

Joseph,
H; Springer, E.  Methadone
maintenance treatment and the AIDS epidemic. 
In:  The Effectiveness of Drug Abuse
Treatment: Dutch and American Perspectives
. p 261-274. 
Malabar, Florida: Robert E. Krieger, 1990.

 

Kreek,
M.J.  Health consequences
associated with the use of methadone. 
In:  Cooper, J.R.;
Altman, F.; Brown, B.S.; Czechowicz, D. (eds), Research
on the Treatment of Narcotic Addiction: 
State of the Art
(NIDA Research Monograph 83-1201). 
Rockville, MD: National Institute on Drug Abuse, 1983.

 

Platt,
J.J.  Heroin Addiction: 
Theory, Research and Treatment
. 
Malabar, FL:  Kreiger, 1988. 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 1 Evaluation of Treatments
. 
Cambridge:  Ballinger,
1974a.

 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 2 Research on Patients, Treatments, and Outcomes
. 
Cambridge:  Ballinger,
1974b.

 

Sells,
S.B; Simpson, D.D. The case for drug abuse treatment effectiveness,
based on the DARP research program. British
Journal of Addiction
1980 75: 117-131.

 

Sells, S.B; Simpson, D.D. Effectiveness
of Drug Abuse Treatment: Volume 3 Further Studies of Drug Users,
Treatment Typologies and Assessment of Outcome During Treatment in the
DARP
.  Cambridge: 
Ballinger, 1976a.

 

Sells, S.B.; Simpson, D.D. 
Effectiveness
of Drug Abuse Treatment: Volume 4 Evaluation of Treatment Outcomes for
the 1971-1972 Admission Cohort
. 
Cambridge:  Ballinger,
1976b.

 

Sells, S.B.; Simpson, D.D. 
Effectiveness
of Drug Abuse Treatment: Volume 5 Evaluation of Treatment Outcomes for
the 1972-1973 Admission Cohort
. 
Cambridge:  Ballinger,
1976c.



Goldstein,
D.  Personal communication,
Eli Lilly Pharmaceuticals, 1992.

 

Joseph,
H; Springer, E.  Methadone
maintenance treatment and the AIDS epidemic. 
In:  The Effectiveness of Drug Abuse
Treatment: Dutch and American Perspectives
. p 261-274. 
Malabar, Florida: Robert E. Krieger, 1990.

 

Kreek,
M.J.  Health consequences
associated with the use of methadone. 
In:  Cooper, J.R.;
Altman, F.; Brown, B.S.; Czechowicz, D. (eds), Research
on the Treatment of Narcotic Addiction: 
State of the Art
(NIDA Research Monograph 83-1201). 
Rockville, MD: National Institute on Drug Abuse, 1983.

 

Platt,
J.J.  Heroin Addiction: 
Theory, Research and Treatment
. 
Malabar, FL:  Kreiger, 1988. 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 1 Evaluation of Treatments
. 
Cambridge:  Ballinger,
1974a.

Similar Posts

  • |

    Food and Drug Administration Alert

    Admin 08/11/2022

    T01-15 April 20, 2001 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA FDA Warns About Orlaam The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction…

  • |

    Methadone Maintenance Treatment and Clinical Issues by Herman Joseph

    Admin 05/01/2021

    The History of Methadone Maintenance Methadone maintenance treatment has been thoroughly researched and carefully evaluated for almost three decades. It has received more scientific scrutiny and evaluation than any other medical treatment or human service program (Ball & Ross, 1991; Brecher, 1972; Des Jarlais, Joseph, Dole & Schmeidler, 1983; Dole & Joseph, 1978; Dole &…

  • The Discovery of Endorphins

    Admin 02/02/2023

    For years it had been suspected that opiates had specificbinding sites in the brain. There were several attempts tolocate these sites, but the existing technologies were unable todistinguish between the non specific binding to tissue and thespecific binding to receptors. It must be mentioned here thatthe first attempt to actually measure specific opiate bindingwas in…

  • Membership Application

    Admin 11/15/2021

    Send To: National Alliance of Methadone Advocates Inc.                                                                                                     Back To NAMA Home Page NAMA Membership Office 435 Second Avenue New York, NY 11000 Membership Application Name:   _______________________________________________________  Organization:  ________________________________________________________________________ Title:  ________________________________________________________ Degree(s):__________________________ Address:  ________________________________________________________________________ Address:  ________________________________________________________________________ City:   _____________________________________    State:   ______Postal Code:   ________Country:   ___ Home Phone: (___)__________________________   Work Phone:   (___)______________________    Alternate Phone:(___)________________________Fax:   (___)______________________________       Email:______________________________________ If you have email may we send you…

  • Carmen Beatrice Pearman Arlt, LMSW, CAC, CMA 1955 – 2019

    Admin 03/01/2023

    Carmen Beatrice Pearman Arlt, LMSW, CAC, CMA 1955 – 2019 NAMA Recovery    Press Release    May 6, 2019  |  0 National Alliance for Medication Assisted RecoveryPress ReleaseContacts Persons: Joycelyn Woods, Executive Director, [email protected]Carmen Pearman-Arlt, President, [email protected]♰Phone/Fax: 1.212.595.NAMA  (1-212-595-62620For ReleaseMay 6, 2019 64, passed away December 9, 2018 after a long illness.In the early 1990s NAMA Recovery was…